# Ambry Genetics

Source: https://onco.cc/companies/ambry-genetics/  
OnCo record `ambry-genetics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Ambry Genetics is a US genetic testing laboratory whose hereditary cancer panels include CancerNext and BRCAplus.

## Summary

A clinical laboratory in California (CLIA 05D0981414, NIH Genetic Testing Registry laboratory 61756) with hereditary cancer panels registered in GTR: CancerNext (41 genes), CancerNext-Expanded (90 genes), BRCAplus (13 genes), and versions of each with paired RNA analysis (RNAinsight). Each is registered as a test developed by the laboratory.

## Fields

- Kind: Company
- Last checked: 2026-11-04
- Also known as: Ambry
- Tags: gap-fill
- HQ: California
- Type: diagnostics
- Website: https://www.ambrygen.com/

## Notes

- Ownership, founding year and headcount were not read in this round and are not recorded.

## Sources

- Ambry Genetics: https://www.ambrygen.com/
- NIH Genetic Testing Registry data file (test_version.gz): https://ftp.ncbi.nlm.nih.gov/pub/GTR/data/test_version.gz

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Prevention & Risk](https://onco.cc/fronts/prevention/)
- technologies: [Germline (hereditary) testing](https://onco.cc/technologies/germline-testing/)
- terms: [Hereditary cancer syndromes](https://onco.cc/terms/hereditary-cancer-syndromes/)
- drugs: [BRCAplus (Ambry Genetics)](https://onco.cc/drugs/ambry-brcaplus/), [CancerNext and CancerNext-Expanded (Ambry Genetics)](https://onco.cc/drugs/ambry-cancernext/)

---
JSON: https://onco.cc/api/v1/entities/ambry-genetics.json